Jackson Acquisition Company is a special purpose acquisition Company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination in any industry or geographic location, the Company intends to concentrate its search on businesses with a focus on healthcare services, healthcare technology, or otherwise focused on the healthcare industry.
Company profile
Ticker
RJAC
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
IRS number
862494888
RJAC stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
23 Jun 23
25-NSE
Exchange delisting
13 Jun 23
10-Q
2023 Q1
Quarterly report
12 May 23
10-K
2022 FY
Annual report
29 Mar 23
25-NSE
Exchange delisting
9 Jan 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
6 Jan 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
12 Aug 22
10-Q
2022 Q1
Quarterly report
23 May 22
NT 10-Q
Notice of late quarterly filing
16 May 22
Latest ownership filings
SC 13G/A
Saba Capital Management, L.P.
9 Feb 24
SC 13G/A
Sculptor Capital LP
14 Feb 23
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 23
SC 13G/A
Saba Capital Management, L.P.
14 Feb 23
SC 13G/A
Polar Asset Management Partners Inc.
13 Feb 23
SC 13G
HIGHBRIDGE CAPITAL MANAGEMENT LLC
2 Feb 23
SC 13G/A
Magnetar Financial LLC
24 Jan 23
SC 13G
Antara Capital LP
3 Mar 22
SC 13G/A
CITADEL ADVISORS LLC
14 Feb 22
SC 13G
RJ Healthcare SPAC, LLC
11 Feb 22
Financial summary
Quarter (USD) | Mar 23 | Dec 22 | Sep 22 | Jun 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 134.23 k | 134.23 k | 134.23 k | 134.23 k | 134.23 k | 134.23 k |
Cash burn (monthly) | 56.96 k | 61.90 k | (no burn) | (no burn) | 179.52 k | 44.88 k |
Cash used (since last report) | 756.53 k | 822.08 k | n/a | n/a | 2.38 mm | 596.04 k |
Cash remaining | -622.30 k | -687.85 k | n/a | n/a | -2.25 mm | -461.82 k |
Runway (months of cash) | -10.9 | -11.1 | n/a | n/a | -12.5 | -10.3 |
Institutional ownership, Q3 2023
28.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 6.42 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
RJ Healthcare SPAC | 5.64 mm | $0.00 |
Integrated Core Strategies | 789.66 k | $0.00 |
Proequities | 0.00 | $0.00 |